VanEck Vectors Biotech ETF (BBH) Stock
Key stats
- Market cap
- $466.04M
- Price / Earnings ratio
- 0.0x
- Volume
- Loading
- 52-week high
- $246.55
- 52-week low
- $172.92
Source: third-party data provider, as of October 17, 2026
Recent news

Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
BBH

Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy?
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy?
BBH

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
BBH

Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues
Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues
BBH
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 60.13
- MACD 12/26/9
- 1.81
- EMA 9 of MACD
- 1.96
- MACD histogram
- -0.14
- SMA 50
- $235.23
- Price above SMA 50
- EMA 50
- $232.63
- Price above EMA 50
- SMA 200
- $203.56
- Price above SMA 200
- EMA 200
- $209.08
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 15, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
No data available
Debt & Balance Sheet
No data available
Revenue to Profit
No data available
Earnings
No data available
Source: third-party data provider
Latest news

Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
BBH

Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy?
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy?
BBH

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
BBH

Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues
Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues
BBH

Should You Invest in the VanEck Biotech ETF (BBH)?
Should You Invest in the VanEck Biotech ETF (BBH)?
BBH

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?
BBH

IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?
IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?
BBH

Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026?
Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026?
BBH

Should You Invest in the VanEck Biotech ETF (BBH)?
Should You Invest in the VanEck Biotech ETF (BBH)?
BBH

Which is the Better Choice for Healthcare Investors? IYH or BBH?
Which is the Better Choice for Healthcare Investors? IYH or BBH?
BBH
News tone: automated (AI) classification of the article's content, not a price prediction.
About VanEck Vectors Biotech ETF
VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
Fundamentals
Trading
Dividend
Source: third-party data provider, as of October 17, 2026
Technical indicators
- RSI 14
- 60.13
- MACD 12/26/9
- 1.81
- EMA 9 of MACD
- 1.96
- MACD histogram
- -0.14
- SMA 50
- $235.23
- Price above SMA 50
- EMA 50
- $232.63
- Price above EMA 50
- SMA 200
- $203.56
- Price above SMA 200
- EMA 200
- $209.08
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 15, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +2.6 | -2.7 | -0.8 | |||||||||
| 2022 | -11.6 | -6.5 | +4.1 | -11.8 | -0.4 | -0.3 | +3.5 | -4.3 | -4.8 | +9.6 | +6.4 | -5.7 |
| 2023 | +5.8 | -6.9 | +2.8 | -1.4 | -3.8 | +0.6 | +3.2 | +2.8 | -5.6 | -6.5 | +3.5 | +7.6 |
| 2024 | -2.3 | -2.7 | +0.3 | -6.0 | +3.8 | +1.2 | +7.1 | -0.1 | -0.5 | -3.9 | -2.0 | -5.9 |
| 2025 | +5.2 | -0.5 | -3.2 | -0.9 | -1.1 | +2.6 | +4.2 | +1.6 | -0.4 | +5.2 | +9.9 | -2.6 |
| 2026 | +3.4 | +0.4 | -4.2 | -2.1 | +3.0 | +9.3 | +0.5 | +15.7 | +2.1 | +3.2 |
Corporate actions
Upcoming
No upcoming corporate actions for BBH




